We have investigated the effects of different patterns of administrati
on of recombinant human growth hormone (rhGH) on weight gain, organ gr
owth, serum GH binding protein (GHBP) and insulin-like growth factor-1
(IGF-1) levels in a series of studies using hypophysectomized (Hx) or
GH-deficient dwarf (dw/dw) rats. Animals were given rhGH either by su
bcutaneous (s.c.) injections (1 or 2 per day) or s.c. infusions and rh
lCF-1 (2 mg/kg/day) by s.c. infusion. In Hx rats, all rhGH regimes inc
reased body weight, tibial epiphyseal plate width, and organ weights i
n a dose-related manner. Dwarf rats showed a smaller growth response t
o rhGH than Hx rats, whereas rhGH induced greater elevations in serum
GHBP in drarf rats. Growth responses depended on the pattern of rhGH a
dministration (twice daily injections > continuous infusions > daily i
njections). The shape of the body growth curves also differed; rhGH in
jections increased weight gain linearly, whereas infusions gave an ini
tial rapid weight gain which slowed with time (a curvilinear response)
. For both regimens, tibial epiphyseal plate width increased linearly
with rhGH dose but infusions were 5-fold more potent than daily inject
ions. Spleen and thymus weights were markedly increased by rhGH and we
re also affected by the pattern of GH exposure. At 5 mg rhGH/kg/day, t
hymus weights were 390 +/- 35 mg for injections vs. 613 +/- 34 mg for
infusions (P < 0.001) compared with 248 +/- 16 mg in vehicle-treated H
x controls. Infusions of rhlGF-1 also stimulated specific organ growth
bud caused less weight gain. RhlGF-1 additively increased the weight
gain caused by rhGH injections but not by rhgH infusions. Circulating
IGF-1 and GHBP levels were increased in a dose-dependent manner by rhG
H infusion, whereas daily injections were ineffective. Thus, different
ial organ growth could be related to the higher serum IGF-1 concentrat
ions induced by continuous rhGH administration. These studies show tha
t whole body growth is best maintained by intermittent rhGH exposure,
whereas, paradoxically, differential organ growth is most pronounced w
ith continuous rhGH administration.